First Trust Advisors LP grew its holdings in shares of LifeVantage Corp (NASDAQ:LFVN) by 18.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 23,106 shares of the company’s stock after purchasing an additional 3,634 shares during the period. First Trust Advisors LP owned approximately 0.16% of LifeVantage worth $305,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Man Group plc bought a new stake in shares of LifeVantage during the 3rd quarter valued at $147,000. Marshall Wace LLP purchased a new position in shares of LifeVantage during the 3rd quarter valued at $167,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of LifeVantage during the 3rd quarter valued at $393,000. GSA Capital Partners LLP purchased a new position in shares of LifeVantage during the 3rd quarter valued at $398,000. Finally, JPMorgan Chase & Co. lifted its stake in shares of LifeVantage by 96.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,119 shares of the company’s stock valued at $419,000 after buying an additional 18,755 shares in the last quarter. Hedge funds and other institutional investors own 32.46% of the company’s stock.
Shares of LFVN stock opened at $11.66 on Friday. The firm has a market capitalization of $166.55 million, a price-to-earnings ratio of 22.86 and a beta of 0.75. LifeVantage Corp has a 52 week low of $3.68 and a 52 week high of $17.08. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.06 and a current ratio of 1.52.
WARNING: “First Trust Advisors LP Has $305,000 Position in LifeVantage Corp (LFVN)” was originally reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/27/first-trust-advisors-lp-raises-position-in-lifevantage-corp-lfvn.html.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Featured Story: Google Finance
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.